{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:50:57Z","timestamp":1793263857168,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 156256"],"award-info":[{"award-number":["PJT 156256"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["WI2-179934"],"award-info":[{"award-number":["WI2-179934"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science &amp; Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.socscimed.2025.118759","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:19:42Z","timestamp":1764001182000},"page":"118759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic"],"prefix":"10.1016","volume":"391","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-0903","authenticated-orcid":false,"given":"Ipek","family":"Eren Vural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5319-6199","authenticated-orcid":false,"given":"Matthew","family":"Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-8122","authenticated-orcid":false,"given":"Janice E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.socscimed.2025.118759_bib1","series-title":"Science, Politics and the Pharmaceutical Industry Controversy and Bias in Drug Regulation","author":"Abraham","year":"1995"},{"issue":"4\u20135","key":"10.1016\/j.socscimed.2025.118759_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0896920513507789","article-title":"Democracy against neoliberalism: paradoxes, limitations, transcendence","volume":"41","author":"Ayers","year":"2015","journal-title":"Crit. Sociol."},{"key":"10.1016\/j.socscimed.2025.118759_bib4","series-title":"State Transformations: Classes, State, Socialism","article-title":"From Canadian state to the making of global capitalism","author":"Barrow","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118759_bib5","series-title":"Health Advocacy Inc. How Pharmaceutical Funding Changed the Breast Cancer Movement","author":"Batt","year":"2017"},{"key":"10.1016\/j.socscimed.2025.118759_bib6","series-title":"Regulating Business by Independent Commission","author":"Bernstein","year":"1955"},{"key":"10.1016\/j.socscimed.2025.118759_bib7","article-title":"\u2018Early Development of Vaccines-regulatory aspects\u2019 COVID-19 vaccine clinical trial discussion forum","author":"Bettle","year":"2020","journal-title":"Scientific Webinar Series"},{"key":"10.1016\/j.socscimed.2025.118759_bib8","series-title":"Regulatory Aspects of Vaccine Development, Director, Center for Regulatory Excellence, Statistics, and Trials, Biologics and Radiopharmaceuticals Directorate, CADTH Covid-19 Vaccine Webinar","author":"Bettle","year":"2020"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118759_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJMra1510061","article-title":"Adaptive designs for clinical trials","volume":"375","author":"Bhatt","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.socscimed.2025.118759_bib10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMms1604593","article-title":"Assessing the Gold Standard--Lessons from the history of RCTs","volume":"374","author":"Bothwell","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.socscimed.2025.118759_bib11","series-title":"The State and Political Theory","author":"Carnoy","year":"1984"},{"key":"10.1016\/j.socscimed.2025.118759_bib12","series-title":"Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA","author":"Carpenter","year":"2010"},{"key":"10.1016\/j.socscimed.2025.118759_bib13","series-title":"Preventing Regulatory Capture: Special Interest Influence and How to Limit it","article-title":"Detecting and measuring capture","author":"Carpenter","year":"2013"},{"key":"10.1016\/j.socscimed.2025.118759_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(21)00085-4","article-title":"The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines","volume":"397","author":"Cavaleri","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.socscimed.2025.118759_bib15","author":"Chan"},{"key":"10.1016\/j.socscimed.2025.118759_bib16","author":"Cooke"},{"key":"10.1016\/j.socscimed.2025.118759_bib17","series-title":"Pharmacopolitics : Drug Regulation in the United States and Germany","author":"Daemmrich","year":"2004"},{"key":"10.1016\/j.socscimed.2025.118759_bib18","series-title":"Unhealthy Pharmaceutical Regulation","author":"Davis","year":"2013"},{"key":"10.1016\/j.socscimed.2025.118759_bib19","article-title":"Will COVID-19 vaccines save lives? Current trials are not designed to tell us","volume":"371","author":"Doshi","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.socscimed.2025.118759_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/13501760500161472","article-title":"Globalization, harmonization, and competition: the different pathways to policy convergence","volume":"12","author":"Drezner","year":"2005","journal-title":"J. Eur. Publ. Pol."},{"key":"10.1016\/j.socscimed.2025.118759_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156118","article-title":"Understanding vaccine hesitancy in Canada: results of a consultation with key stakeholders done by the Canadian immunization research network","author":"Dub\u00e9","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.socscimed.2025.118759_bib23","series-title":"Regulation: a Primer","author":"Dudley","year":"2012"},{"issue":"3","key":"10.1016\/j.socscimed.2025.118759_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/048661349402600312","article-title":"Toward a critical history of methodological individualism","volume":"26","author":"Efaw","year":"1994","journal-title":"Rev. Radic. Polit. Econ."},{"key":"10.1016\/j.socscimed.2025.118759_bib28","series-title":"Annual Report 2021: the European Medicine Agency's Contribution to Science, Medicines, and Health in 2021","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118759_bib29","series-title":"Impure Science: AIDS, Activism, and the Politics of Knowledge","author":"Epstein","year":"1996"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118759_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.healthpol.2021.04.018","article-title":"From sandbox to pandemic: agile reform of Canadian drug regulation","volume":"125","author":"Eren Vural","year":"2021","journal-title":"Health Policy"},{"key":"10.1016\/j.socscimed.2025.118759_bib31","article-title":"Biopharmaceutical financialisation and public funding of medical countermeasures (MCMs) in Canada during the COVID-19 pandemic","author":"Eren Vural","year":"2023","journal-title":"Int. J. Health Pol. Manag."},{"key":"10.1016\/j.socscimed.2025.118759_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01115064","article-title":"Predatory, developmental, and other apparatuses: a comparative political economy perspective on the third world state","volume":"4","author":"Evans","year":"1989","journal-title":"Sociol. Forum"},{"issue":"2","key":"10.1016\/j.socscimed.2025.118759_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S0043887114000057","article-title":"Domestic institutions beyond the nation-state: charting the new interdependence approach","volume":"66","author":"Farrell","year":"2014","journal-title":"World Polit."},{"key":"10.1016\/j.socscimed.2025.118759_bib35","series-title":"Anthony Fauci on the the Take out Show","author":"Fauci","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib36","series-title":"Transparency, Power, and Influence in the Pharmaceutical Industry: Policy Gain or Confidence Game?","author":"Fierlbeck","year":"2021"},{"issue":"7","key":"10.1016\/j.socscimed.2025.118759_bib39","article-title":"Regulatory impact analysis statement, regulations amending food & drug regulations (Interim Order respecting the Sale and Advertising of drugs for use in relation to COVID-19), SOR\/2021-45","volume":"155","year":"2021","journal-title":"Canada Gazette, Part II"},{"key":"10.1016\/j.socscimed.2025.118759_bib40","series-title":"Selection from the Prison Notebooks","author":"Gramsci","year":"1971"},{"issue":"3\u20134","key":"10.1016\/j.socscimed.2025.118759_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11127-022-01005-0","article-title":"Capture and passive predation in times of COVID-19 pandemic","volume":"193","author":"Guennif","year":"2022","journal-title":"Public Choice"},{"key":"10.1016\/j.socscimed.2025.118759_bib42","author":"Hahn"},{"key":"10.1016\/j.socscimed.2025.118759_bib43","series-title":"Oxford Handbook of Contextual Political Analysis","article-title":"Political ontology chapter 4","author":"Hay","year":"2006"},{"key":"10.1016\/j.socscimed.2025.118759_bib44","series-title":"Consultation Summary Health Products Stakeholder Engagement Session","year":"2018"},{"key":"10.1016\/j.socscimed.2025.118759_bib45","series-title":"Premarket Review of Remdesivir (Veklury), Bureau of Gastroenterology, Infection &Viral Diseases, Therapeutic Products Directorate, Science Roadshow","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118759_bib46","series-title":"Presentation Slides Used in Hc's 2020 Virtual Stakeholder Meeting on Health Products","article-title":"HC's regulatory response to COVID-19: expediting access to critical health products","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib48","article-title":"Mechanisms of regulatory capture: testing claims of industry influence in the case of Vioxx","author":"Heims","year":"2023","journal-title":"Regul. Gov."},{"key":"10.1016\/j.socscimed.2025.118759_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/1468-0009.12413","article-title":"Pharmaceutical drugs of uncertain value, lifecycle regulation at the US food and drug administration and institutional incumbency","author":"Herder","year":"2019","journal-title":"Milbank Q."},{"key":"10.1016\/j.socscimed.2025.118759_bib50","series-title":"Beyond the State","first-page":"76","article-title":"The problem of legitimacy","author":"Hoffman","year":"1995"},{"key":"10.1016\/j.socscimed.2025.118759_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.socscimed.2015.01.023","article-title":"Neoliberal technocracy: explaining how and why the US food and drug administration has championed pharmacogenomics","volume":"131","author":"Hogarth","year":"2015","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2025.118759_bib52","series-title":"The SAGE Handbook of Industrial Relations","first-page":"258","article-title":"The state in industrial relations","author":"Hyman","year":"2008"},{"key":"10.1016\/j.socscimed.2025.118759_bib57","unstructured":"International Coalition of Medicines Regulatory Authorities (ICMRA) 2018 Terms of Reference and Rules of Procedure, Version 13, November 2018."},{"key":"10.1016\/j.socscimed.2025.118759_bib58","series-title":"State Theory: Putting the Capitalist State in its Place","author":"Jessop","year":"1990"},{"key":"10.1016\/j.socscimed.2025.118759_bib59","series-title":"At the 161st Meeting of the Vaccines &Related Biological Products","article-title":"Food and drug administration, Center for biologics evaluation and research presentation","author":"Johnson","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib60","series-title":"The Worlds of Political Economy","year":"1988"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118759_bib61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3152\/030234209X460980","article-title":"Multiple institutional rationalities in the regulation of health technologies: an ethnographic examination","volume":"36","author":"Jones","year":"2009","journal-title":"Sci. Publ. Pol."},{"issue":"18","key":"10.1016\/j.socscimed.2025.118759_bib62","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.vaccine.2021.03.060","article-title":"COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER)","volume":"39","author":"Kochhar","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.socscimed.2025.118759_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.pu.07.050186.001245","article-title":"International drug regulation","volume":"7","author":"Lee","year":"1986","journal-title":"Annu. Rev. Publ. Health"},{"key":"10.1016\/j.socscimed.2025.118759_bib64","doi-asserted-by":"crossref","DOI":"10.64590\/bus","article-title":"Marxism and methodological individualism","author":"Levine","year":"1987","journal-title":"New Left Rev."},{"key":"10.1016\/j.socscimed.2025.118759_bib65","series-title":"Private Profits Versus Public Policy: the Pharmaceutical Industry and the Canadian State","author":"Lexchin","year":"2016"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118759_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cpt.1932","article-title":"Pandemic best regulatory practices: an urgent need in the COVID-19 pandemic","volume":"108","author":"Lumpkin","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.socscimed.2025.118759_bib67","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1139\/facets-2021-0037","article-title":"Royal Society of Canada COVID-19 report: enhancing COVID-19 vaccine acceptance in Canada","volume":"6","author":"MacDonald","year":"2021","journal-title":"FACETS"},{"key":"10.1016\/j.socscimed.2025.118759_bib68","series-title":"Regulating Europe","article-title":"Regulatory legitimacy","volume":"13","author":"Majone","year":"1996"},{"key":"10.1016\/j.socscimed.2025.118759_bib69","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/soej.12494","article-title":"The FDA and the COVID-19: a political economy perspective","volume":"87","author":"March","year":"2021","journal-title":"South. Econ. J."},{"key":"10.1016\/j.socscimed.2025.118759_bib70","series-title":"FDA Consumer Magazine, the Centennial Edition, January- February","article-title":"\u2018Promoting Safe and Effective Drugs for 100 years\u2019","author":"Meadows","year":"2006"},{"key":"10.1016\/j.socscimed.2025.118759_bib72","series-title":"Faur Handbook on the Politics of Regulation","first-page":"34","article-title":"Capturing \u201ccapture\u201d: definition and Mechanisms","author":"Mitnick","year":"2011"},{"key":"10.1016\/j.socscimed.2025.118759_bib73","series-title":"The Emergent Design Sage Encyclopaedia of Qualitative Research Methods","author":"Morgan","year":"2008"},{"key":"10.1016\/j.socscimed.2025.118759_bib74","series-title":"Regulating Medicines in a Globalized World: the Need for Increased Reliance Among Regulators","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib75","series-title":"The Fiscal Crisis of the State","author":"O'Connor","year":"1973"},{"key":"10.1016\/j.socscimed.2025.118759_bib76","first-page":"67","article-title":"\u201cTwo Logics of Collective Action: theoretical Notes on Social Class and Organizational Form\u201d","volume":"1","author":"Offe","year":"1980","journal-title":"Polit. Power Soc. Theor."},{"key":"10.1016\/j.socscimed.2025.118759_bib77","series-title":"Dialectical Investigation","author":"Ollman","year":"1993"},{"key":"10.1016\/j.socscimed.2025.118759_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.socscimed.2025.118759_bib79","series-title":"The Canadian State: Political Economy and Political Power","year":"1977"},{"key":"10.1016\/j.socscimed.2025.118759_bib80","series-title":"\u2018A Covid Vaccine Has Arrived. Get Ready for the Rollout\u2019","author":"Paton","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib81","series-title":"FDA Publishes Vaccine Guidelines Opposed by White House","author":"Perrone","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib82","series-title":"Beyond the Welfare State","author":"Pierson","year":"1998"},{"key":"10.1016\/j.socscimed.2025.118759_bib83","series-title":"Competitive Strategy: Techniques for Analysing Industries and Competitors","author":"Porter","year":"1998"},{"key":"10.1016\/j.socscimed.2025.118759_bib84","series-title":"State, Power and Socialism","author":"Poulantzas","year":"1978"},{"issue":"2","key":"10.1016\/j.socscimed.2025.118759_bib85","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/09692290110126128","article-title":"The State, regulation, and global restructuring: reasserting the political in political economy","volume":"9","author":"Purcell","year":"2002","journal-title":"Rev. Int. Polit. Econ."},{"issue":"10","key":"10.1016\/j.socscimed.2025.118759_bib86","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/17512433.2020.1821650","article-title":"Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems","volume":"13","author":"Saint-Raymond","year":"2020","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.socscimed.2025.118759_bib87","series-title":"Realism and Social Science","author":"Sayer","year":"2000"},{"key":"10.1016\/j.socscimed.2025.118759_bib88","series-title":"Bringing Back the State","article-title":"Bringing the state back in: strategies of analysis in current research","author":"Skocpol","year":"1985"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118759_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3003160","article-title":"The theory of economic regulation","volume":"2","author":"Stigler","year":"1971","journal-title":"Bell J. Econ. Manag. Sci."},{"key":"10.1016\/j.socscimed.2025.118759_bib90","article-title":"How the U.K. beat the U.S. and Europe to a Covid-19 vaccine","author":"Strasburg","year":"2020","journal-title":"Wall St. J."},{"key":"10.1016\/j.socscimed.2025.118759_bib91","author":"Topol"},{"key":"10.1016\/j.socscimed.2025.118759_bib92","series-title":"The Politics of Bureaucracy","author":"Tullock","year":"1965"},{"key":"10.1016\/j.socscimed.2025.118759_bib93","article-title":"Adaptive designs for clinical trials of drugs and biologics","year":"2019","journal-title":"Guidance for Industry"},{"key":"10.1016\/j.socscimed.2025.118759_bib94","series-title":"COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) Initiative","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118759_bib95","article-title":"Pharmaceutical (re) capture","author":"Vertinsky","year":"2021","journal-title":"Soc. Sci. Res."},{"key":"10.1016\/j.socscimed.2025.118759_bib96","series-title":"The Politics of Precaution: Regulating Health, Safety, and Environmental Risks in Europe and the United States","author":"Vogel","year":"2012"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118759_bib97","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/13563467.2021.1994545","article-title":"Explaining divergent national responses to Covid-19: an enhanced state capacity framework","volume":"27","author":"Weiss","year":"2022","journal-title":"New Polit. Econ."},{"key":"10.1016\/j.socscimed.2025.118759_bib99","series-title":"Novel Coronavirus, an International Randomised Trial of Candidate Vaccines Against COVID-19","year":"2020"},{"key":"10.1016\/j.socscimed.2025.118759_bib100","series-title":"Solidarity Trial Vaccines an International Randomised Trial of Candidate Vaccines Against COVID-19","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118759_bib101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12992-018-0402-5","article-title":"Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence","volume":"14","author":"Wiktorowicz","year":"2018","journal-title":"Global Health"},{"issue":"December","key":"10.1016\/j.socscimed.2025.118759_bib102","first-page":"387","article-title":"Economic theories of state or economics imperialism: rent seeking analysis as an exemplar","volume":"34","author":"Yalman","year":"2007","journal-title":"METU Studies in Development"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118759_sref103","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamainternmed.2020.2402","article-title":"Need for transparency and reliable evidence in emergency use authorizations for coronavirus disease (2019) (COVID-19) therapies","volume":"180","author":"Zhai","year":"2020","journal-title":"JAMA Intern. Med."}],"container-title":["Social Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625010901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625010901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:36:27Z","timestamp":1781771787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953625010901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":88,"alternative-id":["S0277953625010901"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118759","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118759"}}